• 1. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 5. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes

Introduction to 2-(2,4-dichlorophenyl)ethanethioamide (CAS No. 883946-62-1) in Modern Chemical and Pharmaceutical Research

The compound 2-(2,4-dichlorophenyl)ethanethioamide, identified by the chemical abstracts service number 883946-62-1, represents a significant area of interest in the realm of chemical and pharmaceutical research. This heterocyclic thioamide derivative has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The presence of both chloro substituents on the aromatic ring and the thioamide functional group makes this molecule a promising candidate for further exploration, particularly in the development of novel therapeutic agents.

Recent advancements in computational chemistry and molecular modeling have allowed researchers to delve deeper into the interactions of 2-(2,4-dichlorophenyl)ethanethioamide with biological targets. The dichlorophenyl moiety is known to enhance lipophilicity, which is a critical factor in drug bioavailability. Simultaneously, the thioamide group introduces a polar region that can interact with biological molecules through hydrogen bonding or ionic interactions. This dual functionality makes the compound an attractive scaffold for designing molecules with tailored pharmacokinetic profiles.

In the context of drug discovery, 2-(2,4-dichlorophenyl)ethanethioamide has been investigated for its potential role as an intermediate in synthesizing more complex pharmacophores. The dichlorophenyl ring can serve as a versatile platform for further functionalization, allowing chemists to introduce additional substituents that may enhance binding affinity or selectivity against specific biological targets. For instance, studies have shown that derivatives of this compound exhibit inhibitory activity against certain enzymes and receptors, making them relevant in treating conditions such as inflammation and neurodegeneration.

The synthesis of 2-(2,4-dichlorophenyl)ethanethioamide involves multi-step organic reactions that require precise control over reaction conditions. The chlorination step is particularly critical, as it determines the electronic properties of the aromatic ring. Advanced synthetic methodologies, such as catalytic chlorination or electrochemical methods, have been employed to achieve high yields and purity. These techniques not only improve efficiency but also minimize waste, aligning with modern green chemistry principles.

One of the most compelling aspects of 2-(2,4-dichlorophenyl)ethanethioamide is its potential in addressing unmet medical needs. Current research focuses on leveraging its structural features to develop drugs that are more effective and have fewer side effects compared to existing treatments. For example, modifications to the thioamide group have been explored to enhance metabolic stability while maintaining biological activity. Such efforts are supported by high-throughput screening technologies that enable rapid evaluation of large libraries of derivatives.

The role of computational tools in understanding the behavior of 2-(2,4-dichlorophenyl)ethanethioamide cannot be overstated. Molecular dynamics simulations and quantum mechanical calculations provide insights into how this compound interacts with biological targets at an atomic level. These simulations help predict binding affinities, identify key interaction sites, and optimize lead structures before experimental validation. This interdisciplinary approach accelerates the drug discovery process significantly.

Moreover, the environmental impact of synthesizing and using 2-(2,4-dichlorophenyl)ethanethioamide is a growing concern in industrial research. Efforts are underway to develop sustainable synthetic routes that reduce reliance on hazardous reagents and minimize environmental footprints. Techniques such as flow chemistry and biocatalysis are being integrated into production processes to achieve these goals while maintaining high chemical yields.

Future directions in research on 2-(2,4-dichlorophenyl)ethanethioamide include exploring its role in combination therapies and developing prodrugs that enhance bioavailability or target specific tissues. The dichlorophenyl group offers flexibility for designing molecules that can cross biological barriers effectively, while the thioamide moiety provides a site for further functionalization. These attributes make this compound a valuable asset in medicinal chemistry.

In conclusion, 2-(2,4-dichlorophenyl)ethanethioamide (CAS No. 883946-62-1) represents a fascinating subject of study with significant implications for drug development. Its unique structural features and potential applications in treating various diseases position it as a key compound in ongoing pharmaceutical research efforts. As methodologies advance and interdisciplinary collaboration deepens, 883946-62-1 will continue to be at the forefront of innovation in chemical biology.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)